Target intelligence / Profile preview

Jade family PHD finger protein 2 (JADE2)

Target
JADE2
Molecular classification
E3 ubiquitin-protein ligase, Chromatin-associated protein, Histone modification protein (PHD finger domain-containing), Enzyme, Scaffold protein (HBO1 complex component)
01

Overview

Jade family PHD finger protein 2 (JADE2) is an E3 ubiquitin-protein ligase and a chromatin-associated protein distinguished by plant homeodomain (PHD) zinc finger motifs. It participates in the regulation of chromatin structure by acting as a scaffold subunit of certain HBO1 histone acetyltransferase complexes, conferring acetylation activity to specific lysines on histone H4 and contributing to DNA replication and cell cycle regulation[3][5]. JADE2 also mediates ubiquitination and subsequent proteasomal degradation of selected substrates such as the histone demethylase KDM1A, suggesting it plays a role in protein quality control and epigenetic regulation[3][5]. Through these functions, JADE2 impacts DNA synthesis, chromatin remodeling, and potentially neurogenesis. While E3 ubiquitin ligases are considered therapeutic targets in cancer and other diseases, there are no approved drugs that directly target JADE2 to date, and its involvement in disease is based on pathway association and family homology rather than direct clinical evidence[2][3][5].

Other names
E3 ubiquitin-protein ligase Jade-2KIAA0239PHF15JADE-2PHD finger protein 15
02

Mechanism of action

Modulation of protein stability via polyubiquitination and proteasomal degradation (e.g., ubiquitination of histone demethylase KDM1A); Alteration of chromatin structure via histone acetylation as part of HBO1 complex

03

Biological functions

Protein ubiquitinationHistone acetylation (notably H4K12, H4K5, H4K8 acetyltransferase activity)Regulation of DNA replicationCell cycle regulationChromatin organizationRegulation of DNA biosynthetic processPositive regulation of neurogenesis
04

Disease associations

Cancer (potential tumor suppressor or regulator; dysregulation of ubiquitin ligases and chromatin modifiers has been implicated in multiple cancers)Other (neurogenesis, but direct disease links for JADE2 are less established than for other family members)
05

Safety considerations

Potential for disruption of chromatin regulation and protein homeostasis if targeted therapeutically, leading to cell cycle defects or off-target effects in chromatin and protein turnover

Beyond the preview

Go deeper on Jade family PHD finger protein 2 (JADE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jade family PHD finger protein 2 (JADE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call